Search
Oramed Pharmaceuticals Inc
ORMPAdd to Watchlist
4.790USD
+0.070+1.48%
Close 09-24 16:00（ET）
196.05MMarket Cap
1.79P/E TTM
Oramed Pharmaceuticals Inc (ORMP) Stock Price Target & Forecast
Target Price
7.000USD+48.31%
ORMP Analyst Recommendation Trends
In the current month, ORMP has received 0 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. ORMP average Analyst price target in the last month is 7.000.
2026-09
2026-08
2026-07
2026-06
2026-05
2026-04
2026-03
2026-02
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
ORMP Analyst Rating for Peer Comparison
Updated: Sep 24, 2026Company name
Strong Buy
Buy
Hold
Sell
Strong Sell
Analysts
Beigene Ltd
ONC
8
19
0
1
0
28
Ionis Pharmaceuticals Inc
IONS
6
14
6
0
0
26
argenx SE
ARGX
10
13
3
0
0
26
CRISPR Therapeutics AG
CRSP
4
9
11
0
0
24
IQVIA Holdings Inc
IQV
8
12
4
0
0
24
Insmed Inc
INSM
7
17
0
0
0
24
Kymera Therapeutics Inc
KYMR
9
12
2
0
0
23
Revolution Medicines Inc
RVMD
8
13
1
0
0
22
Cytokinetics Inc
CYTK
4
16
2
0
0
22
Tempus AI Inc
TEM
5
6
7
1
1
20
Financial Forecasting
Based on analysts' estimates, ORMP EPS is projected to reach 0.430 in FY2026Q3, following reported EPS of 1.904 in FY2026Q2. Track earnings expectations against reported figures to see how profitability is evolving.
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
FY2025Q4
FY2026Q1
FY2026Q2
FY2025Q3
FY2026Q3
FY2026Q4
Forecast
--
--
0.43
-0.04
0.43
0.37
Actual
0.24
0.94
1.90
--
--
--
Surprise
--
--
+342.87%
--
--
--
FAQs
What is Oramed Pharmaceuticals Inc's price target?
Analysts forecast that Oramed Pharmaceuticals Inc's price target is USD 7.00, with the highest forecast at USD 7.00 and the lowest forecast at USD 7.00.
How have Oramed Pharmaceuticals IncORMP's recent earnings per share performed?
The market expectation was USD 1.90, while Oramed Pharmaceuticals IncORMP's earnings per share (EPS) for the previous quarter was USD 0.94. EPS for the next quarter is expected at USD 0.43.